Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma
Status:
Terminated
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The study is a prospective phase II trial of radiation therapy concurrent with cisplatin
chemotherapy in the treatment of locally advanced or metastatic melanoma in patients who are
deemed to require radiation therapy by treating physicians for purposes of local control or
palliation. Eligibility criteria include pathologically confirmed melanoma. Patients will
undergo radiation therapy (20 treatments of 2.5 Gy for a total of 50 Gy) concurrent with
cisplatin chemotherapy.